Header Logo

Neil Martinson

Concepts (644)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tuberculosis
73
2025
543
13.040
Why?
HIV Infections
176
2024
5097
11.340
Why?
Tuberculosis, Pulmonary
40
2024
324
7.330
Why?
Mycobacterium tuberculosis
37
2024
329
6.510
Why?
Humans
276
2025
14537
5.230
Why?
South Africa
195
2025
7596
5.030
Why?
Antitubercular Agents
38
2024
322
5.010
Why?
Adult
175
2024
5913
4.930
Why?
Male
154
2025
6754
4.430
Why?
Circumcision, Male
19
2024
99
4.230
Why?
Female
171
2025
9103
4.210
Why?
Latent Tuberculosis
14
2023
45
3.700
Why?
Isoniazid
20
2024
110
3.640
Why?
AIDS-Related Opportunistic Infections
16
2021
195
3.460
Why?
Contact Tracing
12
2023
48
3.140
Why?
HIV-1
35
2024
1260
2.750
Why?
CD4 Lymphocyte Count
35
2024
656
2.670
Why?
Middle Aged
80
2024
3601
2.570
Why?
Anti-HIV Agents
37
2024
1324
2.560
Why?
Young Adult
65
2024
2498
2.390
Why?
Sputum
17
2023
135
2.300
Why?
Tuberculosis, Multidrug-Resistant
11
2024
226
2.130
Why?
Antiretroviral Therapy, Highly Active
16
2017
472
2.030
Why?
Hospitalization
13
2024
418
2.000
Why?
Prospective Studies
42
2025
1160
1.990
Why?
Rifampin
15
2023
197
1.990
Why?
Pregnancy Complications, Infectious
18
2020
529
1.870
Why?
Cross-Sectional Studies
44
2023
1422
1.860
Why?
Adolescent
55
2024
2985
1.800
Why?
Anti-Retroviral Agents
12
2024
551
1.790
Why?
Family Characteristics
18
2023
135
1.750
Why?
HIV
14
2023
380
1.750
Why?
Coinfection
12
2022
276
1.600
Why?
Patient Acceptance of Health Care
13
2023
256
1.590
Why?
Viral Load
22
2022
819
1.590
Why?
Infectious Disease Transmission, Vertical
16
2019
472
1.560
Why?
Prevalence
32
2023
1192
1.490
Why?
Sexual Behavior
8
2019
320
1.490
Why?
Tuberculin Test
11
2020
49
1.400
Why?
Nevirapine
14
2017
146
1.380
Why?
Pre-Exposure Prophylaxis
9
2024
196
1.360
Why?
Child
33
2024
2242
1.350
Why?
HIV Seropositivity
7
2023
265
1.240
Why?
Treatment Outcome
19
2024
889
1.220
Why?
Risk Factors
24
2024
1475
1.200
Why?
Aged
28
2024
1740
1.120
Why?
Pregnancy
30
2022
1862
1.090
Why?
Primary Health Care
10
2023
240
1.080
Why?
Influenza, Human
9
2025
374
1.070
Why?
Ambulatory Care Facilities
9
2022
125
1.060
Why?
Infant
26
2025
2244
1.040
Why?
Communicable Disease Control
4
2023
101
1.010
Why?
Incidence
15
2025
685
1.010
Why?
Disease Notification
3
2025
14
0.990
Why?
Bacteriological Techniques
5
2021
54
0.970
Why?
Mass Screening
13
2023
245
0.970
Why?
Health Knowledge, Attitudes, Practice
8
2023
262
0.960
Why?
Surgical Instruments
3
2019
11
0.960
Why?
Drug Resistance, Viral
10
2016
278
0.940
Why?
Cell Phone
3
2020
34
0.930
Why?
Cohort Studies
25
2024
967
0.900
Why?
Foreskin
4
2024
12
0.890
Why?
Child, Preschool
21
2024
1748
0.880
Why?
Surveys and Questionnaires
15
2018
563
0.840
Why?
Infant, Newborn
17
2022
1479
0.830
Why?
Home Care Services
1
2024
15
0.830
Why?
Levofloxacin
5
2024
21
0.820
Why?
Community-Acquired Infections
1
2024
102
0.800
Why?
Exhalation
1
2023
3
0.800
Why?
Smoking Cessation
4
2024
9
0.780
Why?
Cervical Intraepithelial Neoplasia
4
2014
36
0.770
Why?
Drug Therapy, Combination
12
2024
279
0.760
Why?
Rifamycins
1
2022
1
0.760
Why?
Sensitivity and Specificity
13
2023
385
0.760
Why?
Point-of-Care Systems
1
2023
91
0.750
Why?
Tobacco Use Disorder
1
2022
7
0.750
Why?
Cannabis
1
2022
10
0.740
Why?
Pneumococcal Vaccines
2
2024
278
0.740
Why?
Tobacco Smoking
2
2022
15
0.740
Why?
Uterine Cervical Neoplasms
3
2014
115
0.730
Why?
Drug Administration Schedule
12
2022
156
0.730
Why?
Bacterial Load
2
2023
32
0.720
Why?
Predictive Value of Tests
8
2021
188
0.720
Why?
Lung
5
2023
70
0.710
Why?
Rural Population
11
2021
654
0.710
Why?
Time Factors
10
2021
507
0.700
Why?
Mobile Health Units
1
2021
7
0.690
Why?
Air Pollution, Indoor
2
2021
13
0.690
Why?
Molecular Diagnostic Techniques
4
2020
132
0.690
Why?
HLA Antigens
2
2022
50
0.670
Why?
Health Services Accessibility
7
2019
280
0.670
Why?
Condoms
3
2011
88
0.650
Why?
Penis
2
2019
8
0.630
Why?
Follow-Up Studies
10
2021
370
0.620
Why?
Heterosexuality
2
2021
30
0.610
Why?
Smoking
7
2023
100
0.610
Why?
Logistic Models
9
2018
254
0.600
Why?
Antibiotics, Antitubercular
5
2021
47
0.600
Why?
Cost of Illness
4
2020
167
0.600
Why?
Benzoxazines
2
2017
123
0.600
Why?
Urban Population
6
2021
257
0.590
Why?
Pain
2
2018
41
0.580
Why?
Retrospective Studies
10
2023
799
0.570
Why?
Socioeconomic Factors
7
2019
411
0.560
Why?
Medication Adherence
4
2020
151
0.560
Why?
Sexual Partners
5
2021
215
0.560
Why?
Radiography
2
2023
80
0.550
Why?
Tobacco Smoke Pollution
1
2017
5
0.530
Why?
Lung Diseases, Obstructive
1
2017
5
0.530
Why?
Urban Health
3
2021
78
0.520
Why?
Ataxia
1
2017
4
0.520
Why?
Intention
2
2023
23
0.520
Why?
Brain Diseases
1
2017
24
0.510
Why?
Hepatitis B
3
2014
125
0.510
Why?
Wound Healing
2
2016
29
0.510
Why?
Cost-Benefit Analysis
10
2019
253
0.510
Why?
Pleural Cavity
1
2017
7
0.510
Why?
Linear Models
4
2023
83
0.510
Why?
Lamivudine
3
2017
89
0.510
Why?
Rural Health Services
2
2015
48
0.500
Why?
Diabetic Foot
1
2016
1
0.490
Why?
Skin, Artificial
1
2016
1
0.490
Why?
Medicare
1
2016
9
0.490
Why?
Precancerous Conditions
2
2014
10
0.490
Why?
Cause of Death
7
2017
221
0.480
Why?
Genital Diseases, Male
1
2016
8
0.480
Why?
Disease Progression
9
2019
154
0.480
Why?
Respiratory Syncytial Virus Infections
3
2024
200
0.470
Why?
Lipopolysaccharides
3
2011
37
0.460
Why?
Telemedicine
3
2021
25
0.450
Why?
Patient Preference
3
2011
30
0.450
Why?
Inservice Training
1
2015
7
0.450
Why?
Autopsy
6
2023
140
0.450
Why?
Allied Health Personnel
1
2015
6
0.450
Why?
Politics
1
2015
24
0.440
Why?
Pilot Projects
5
2024
179
0.440
Why?
Disease Outbreaks
3
2018
111
0.430
Why?
Risk-Taking
3
2012
121
0.430
Why?
Caregivers
1
2015
76
0.430
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2014
19
0.420
Why?
Diagnostic Tests, Routine
5
2021
59
0.420
Why?
Zidovudine
3
2018
59
0.420
Why?
Product Packaging
1
2014
2
0.420
Why?
Crime
1
2014
3
0.420
Why?
Inpatients
4
2019
30
0.420
Why?
Calcitriol
1
2014
6
0.410
Why?
Tobacco Products
1
2014
8
0.410
Why?
Dermatologic Agents
1
2014
6
0.410
Why?
Zinc Sulfate
1
2014
6
0.410
Why?
Commerce
1
2014
22
0.410
Why?
HIV Long-Term Survivors
1
2014
8
0.410
Why?
Patient Discharge
4
2024
27
0.410
Why?
Health Services Needs and Demand
2
2012
57
0.400
Why?
Extensively Drug-Resistant Tuberculosis
2
2011
20
0.400
Why?
Polymerase Chain Reaction
5
2021
260
0.400
Why?
Delayed Diagnosis
1
2013
17
0.390
Why?
Comorbidity
5
2021
188
0.390
Why?
Time-to-Treatment
1
2013
42
0.390
Why?
Health Care Costs
5
2019
115
0.390
Why?
Floxacillin
1
2013
6
0.380
Why?
Bacillus
2
2023
7
0.380
Why?
Urine
2
2010
6
0.380
Why?
Surgical Wound Infection
1
2013
13
0.380
Why?
Directly Observed Therapy
2
2017
6
0.380
Why?
Risk
4
2019
87
0.380
Why?
High-Throughput Nucleotide Sequencing
3
2024
48
0.370
Why?
Drug-Related Side Effects and Adverse Reactions
2
2023
34
0.370
Why?
Pregnant Women
4
2021
89
0.370
Why?
Reverse Transcriptase Inhibitors
3
2011
118
0.370
Why?
Tenofovir
4
2024
171
0.370
Why?
Deoxycytidine
1
2012
12
0.370
Why?
Antigens, CD
2
2024
26
0.370
Why?
Emtricitabine
4
2023
78
0.360
Why?
CD4-Positive T-Lymphocytes
5
2019
151
0.360
Why?
Sex Workers
4
2022
116
0.360
Why?
Hepatitis C
1
2012
37
0.360
Why?
Counseling
7
2024
143
0.360
Why?
Organophosphonates
1
2012
45
0.360
Why?
Motivation
3
2023
59
0.350
Why?
Consumer Behavior
1
2012
20
0.350
Why?
Family
1
2012
35
0.350
Why?
Adenine
1
2012
91
0.350
Why?
Community Health Services
1
2012
58
0.340
Why?
Genetic Variation
7
2024
175
0.340
Why?
RNA, Viral
8
2019
303
0.340
Why?
Biostatistics
1
2011
4
0.340
Why?
Longitudinal Studies
6
2023
435
0.340
Why?
Smoking Prevention
1
2011
5
0.330
Why?
Activities of Daily Living
1
2011
41
0.330
Why?
Anti-Bacterial Agents
1
2013
293
0.320
Why?
Respiratory Syncytial Virus, Human
2
2024
155
0.320
Why?
Genotype
8
2020
442
0.320
Why?
Sequence Analysis, DNA
6
2019
181
0.320
Why?
Referral and Consultation
1
2010
57
0.320
Why?
Thinness
1
2010
18
0.320
Why?
Health Behavior
1
2011
79
0.310
Why?
Body Mass Index
2
2014
321
0.300
Why?
Continuity of Patient Care
3
2019
33
0.300
Why?
Lymphoma, AIDS-Related
2
2021
16
0.300
Why?
Influenza Vaccines
2
2025
144
0.290
Why?
Choice Behavior
1
2009
16
0.290
Why?
Tuberculosis Vaccines
2
2019
8
0.290
Why?
Funeral Homes
2
2019
6
0.290
Why?
Urban Health Services
1
2009
10
0.290
Why?
Health Expenditures
2
2019
39
0.290
Why?
Sexually Transmitted Diseases
4
2021
103
0.280
Why?
Receptors, IgG
2
2019
28
0.280
Why?
Viremia
3
2019
66
0.280
Why?
Microscopy
3
2021
21
0.280
Why?
Laboratories
3
2021
47
0.280
Why?
Reproductive Medicine
1
2008
4
0.270
Why?
Evolution, Molecular
2
2024
60
0.270
Why?
Pandemics
4
2023
296
0.270
Why?
Communicable Diseases
2
2018
62
0.260
Why?
Patient Compliance
3
2017
120
0.260
Why?
Biomarkers
5
2022
327
0.260
Why?
Delivery of Health Care
3
2018
239
0.260
Why?
Health Personnel
5
2020
231
0.260
Why?
Alleles
5
2020
143
0.260
Why?
Health Resources
2
2012
66
0.260
Why?
Africa
6
2019
376
0.250
Why?
Receptors, CCR5
2
2019
54
0.250
Why?
Proportional Hazards Models
5
2019
163
0.250
Why?
Linezolid
2
2024
22
0.250
Why?
Killer Cells, Natural
2
2024
52
0.250
Why?
Computers, Handheld
1
2006
2
0.250
Why?
Geographic Information Systems
1
2006
6
0.240
Why?
Receptors, Virus
2
2017
5
0.240
Why?
Intraoperative Complications
1
2006
8
0.240
Why?
Disease Susceptibility
3
2022
46
0.240
Why?
Bacterial Infections
2
2019
54
0.240
Why?
Pneumonia
1
2007
131
0.240
Why?
Postpartum Period
4
2019
85
0.230
Why?
Age Factors
5
2019
370
0.230
Why?
Epidemiologic Methods
3
2010
25
0.230
Why?
Asymptomatic Infections
2
2025
34
0.220
Why?
Tight Junctions
1
2024
2
0.220
Why?
Antigens, Differentiation, T-Lymphocyte
1
2024
3
0.220
Why?
Lectins, C-Type
1
2024
4
0.220
Why?
Population Surveillance
1
2006
325
0.220
Why?
Attitude to Health
2
2018
56
0.210
Why?
Reproducibility of Results
4
2020
217
0.210
Why?
Cycloserine
1
2024
2
0.210
Why?
House Calls
1
2024
9
0.210
Why?
Clofazimine
1
2024
8
0.210
Why?
Hospital Mortality
2
2019
95
0.210
Why?
Case-Control Studies
7
2022
480
0.210
Why?
Drug Interactions
1
2024
31
0.200
Why?
Kynurenine
2
2021
7
0.200
Why?
Tryptophan
2
2021
8
0.200
Why?
Mutation
5
2024
306
0.200
Why?
Specimen Handling
3
2020
105
0.200
Why?
Pneumonia, Pneumococcal
1
2024
100
0.200
Why?
Housing
2
2021
24
0.200
Why?
Spike Glycoprotein, Coronavirus
1
2024
101
0.200
Why?
Uganda
5
2024
197
0.200
Why?
Tertiary Care Centers
2
2021
80
0.200
Why?
Lung Diseases
1
2023
29
0.200
Why?
Attitude of Health Personnel
2
2018
106
0.190
Why?
Nicotine
1
2023
12
0.190
Why?
DNA, Viral
2
2020
165
0.190
Why?
Epidemics
1
2023
65
0.190
Why?
Randomized Controlled Trials as Topic
5
2024
244
0.190
Why?
Qualitative Research
3
2021
321
0.190
Why?
Contraceptive Agents
1
2022
27
0.190
Why?
Sexual and Gender Minorities
1
2022
29
0.180
Why?
Multivariate Analysis
3
2013
171
0.180
Why?
Whooping Cough
1
2023
36
0.180
Why?
Chemokine CCL4
1
2022
14
0.180
Why?
Hospitals, Teaching
2
2020
21
0.180
Why?
Anemia, Iron-Deficiency
1
2022
21
0.180
Why?
Prognosis
4
2016
199
0.180
Why?
Monte Carlo Method
2
2013
11
0.180
Why?
Anemia
1
2022
41
0.180
Why?
Vaccination
3
2025
365
0.180
Why?
Rural Health
2
2021
118
0.180
Why?
Enzyme-Linked Immunosorbent Assay
2
2020
150
0.180
Why?
Physical Abuse
1
2022
8
0.180
Why?
Mortality
2
2020
104
0.180
Why?
Gene Rearrangement, T-Lymphocyte
1
2021
3
0.180
Why?
Sex Offenses
1
2022
29
0.180
Why?
Developing Countries
3
2018
400
0.170
Why?
Substance-Related Disorders
1
2022
51
0.170
Why?
Influenza A virus
2
2019
28
0.170
Why?
Dipeptidyl Peptidase 4
1
2021
4
0.170
Why?
Health Facilities
2
2018
40
0.170
Why?
Seroepidemiologic Studies
4
2023
109
0.170
Why?
Nucleic Acids
1
2021
7
0.170
Why?
Serologic Tests
2
2019
26
0.170
Why?
Hospitals
3
2023
103
0.170
Why?
Cell-Free Nucleic Acids
1
2021
6
0.170
Why?
Fatty Acids, Omega-3
1
2021
2
0.170
Why?
Cyclooxygenase Inhibitors
1
2021
4
0.170
Why?
United States
2
2023
132
0.170
Why?
Intensive Care Units
1
2021
66
0.170
Why?
Nucleic Acid Amplification Techniques
1
2021
35
0.170
Why?
Lipid Metabolism
1
2021
44
0.160
Why?
Kaplan-Meier Estimate
3
2024
106
0.160
Why?
Health Promotion
3
2020
109
0.160
Why?
Liver
3
2016
74
0.160
Why?
Biological Assay
1
2020
32
0.160
Why?
Child, Hospitalized
2
2021
26
0.160
Why?
Ethambutol
1
2020
9
0.160
Why?
Pyrazinamide
1
2020
14
0.150
Why?
Feasibility Studies
4
2021
101
0.150
Why?
Alkynes
2
2017
117
0.150
Why?
Pregnancy Outcome
1
2020
117
0.150
Why?
Cyclopropanes
2
2017
123
0.150
Why?
Langerhans Cells
1
2019
3
0.150
Why?
Chemokine CCL27
1
2019
3
0.150
Why?
Morbidity
1
2019
37
0.150
Why?
DNA, Bacterial
2
2016
53
0.150
Why?
Urinary Tract
1
2019
4
0.150
Why?
Pharmacogenomic Variants
1
2019
6
0.150
Why?
Pneumococcal Infections
1
2023
299
0.150
Why?
Standard of Care
1
2019
30
0.150
Why?
Medical Waste Disposal
1
2019
3
0.150
Why?
Safety Management
1
2019
4
0.150
Why?
Vaginal Smears
2
2011
34
0.150
Why?
Amputation, Traumatic
1
2019
2
0.150
Why?
Bacteremia
1
2020
79
0.150
Why?
Tobacco, Smokeless
1
2019
7
0.150
Why?
Patient Readmission
1
2019
6
0.150
Why?
Personal Protective Equipment
1
2019
16
0.150
Why?
Peripartum Period
1
2019
9
0.150
Why?
Pharmaceutical Preparations
1
2019
44
0.150
Why?
Tobacco Use
1
2019
12
0.150
Why?
Self Care
1
2019
14
0.150
Why?
Postoperative Complications
1
2019
34
0.150
Why?
Regulatory Sequences, Nucleic Acid
1
2019
7
0.150
Why?
3' Untranslated Regions
1
2019
9
0.150
Why?
Pain Measurement
2
2016
15
0.150
Why?
Mortuary Practice
1
2019
3
0.140
Why?
Immunogenicity, Vaccine
1
2019
103
0.140
Why?
Clinical Trials as Topic
3
2021
112
0.140
Why?
Phylogeny
3
2024
231
0.140
Why?
Acute Disease
1
2018
105
0.140
Why?
Smokers
1
2018
3
0.140
Why?
Virus Shedding
1
2018
24
0.140
Why?
Poverty
1
2019
152
0.140
Why?
Random Allocation
1
2018
23
0.140
Why?
Orthomyxoviridae
1
2018
33
0.140
Why?
Interferon-gamma Release Tests
3
2024
8
0.140
Why?
Treatment Refusal
2
2016
13
0.140
Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
2018
13
0.140
Why?
Occupational Diseases
1
2019
40
0.140
Why?
Research
1
2019
65
0.140
Why?
Resins, Synthetic
1
2018
3
0.140
Why?
Patient Outcome Assessment
1
2018
8
0.140
Why?
Analgesia
1
2018
8
0.140
Why?
Pain Management
1
2018
12
0.140
Why?
Pathology, Clinical
1
2018
1
0.140
Why?
Research Design
2
2021
124
0.140
Why?
Clinical Laboratory Services
1
2018
4
0.140
Why?
Kerosene
1
2017
4
0.130
Why?
Self Administration
1
2017
5
0.130
Why?
Diarrhea
1
2018
76
0.130
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2017
4
0.130
Why?
Antigens, Bacterial
2
2023
32
0.130
Why?
Interferon-gamma
2
2023
39
0.130
Why?
Zimbabwe
3
2023
120
0.130
Why?
Survival Analysis
3
2016
149
0.130
Why?
Biomedical Research
1
2018
49
0.130
Why?
Directive Counseling
1
2017
15
0.130
Why?
Infant Mortality
1
2018
97
0.130
Why?
Receptors, Chemokine
1
2017
6
0.130
Why?
Dose-Response Relationship, Drug
1
2017
125
0.130
Why?
Polymorphism, Single Nucleotide
4
2020
198
0.130
Why?
Environmental Exposure
1
2017
45
0.130
Why?
Selection, Genetic
2
2007
31
0.130
Why?
GTPase-Activating Proteins
1
2017
3
0.130
Why?
Disease Resistance
1
2017
6
0.120
Why?
Point-of-Care Testing
1
2017
71
0.120
Why?
Azides
1
2016
1
0.120
Why?
Propidium
1
2016
1
0.120
Why?
Acquired Immunodeficiency Syndrome
3
2014
187
0.120
Why?
Acute Kidney Injury
1
2016
15
0.120
Why?
Double-Blind Method
3
2024
272
0.120
Why?
Outpatient Clinics, Hospital
1
2016
17
0.120
Why?
DNA Primers
3
2012
55
0.120
Why?
Odds Ratio
2
2013
133
0.120
Why?
Tissue Engineering
1
2016
52
0.120
Why?
Direct Service Costs
1
2015
3
0.120
Why?
Seasons
3
2023
154
0.120
Why?
Bronchoalveolar Lavage
1
2015
3
0.120
Why?
Self Report
3
2023
114
0.120
Why?
Phenotype
2
2014
158
0.110
Why?
Child Welfare
2
2009
16
0.110
Why?
Lymphocyte Activation
1
2015
40
0.110
Why?
Drug Combinations
2
2012
42
0.110
Why?
Ambulatory Care
2
2018
54
0.110
Why?
Epigenesis, Genetic
1
2015
17
0.110
Why?
Drug Design
1
2015
29
0.110
Why?
Quality Control
1
2015
27
0.110
Why?
T-Lymphocytes
1
2015
65
0.110
Why?
Quality Indicators, Health Care
1
2015
14
0.110
Why?
Automation, Laboratory
1
2015
13
0.110
Why?
Schools
1
2015
73
0.110
Why?
Fatty Liver
1
2015
8
0.110
Why?
Interviews as Topic
2
2018
203
0.110
Why?
Diabetes Mellitus
1
2016
146
0.110
Why?
Reagent Kits, Diagnostic
2
2011
56
0.100
Why?
Papillomavirus Infections
2
2012
74
0.100
Why?
Administration, Cutaneous
1
2014
31
0.100
Why?
HIV Seronegativity
2
2019
52
0.100
Why?
Cities
1
2014
37
0.100
Why?
Cervix Uteri
1
2014
22
0.100
Why?
Gene Frequency
4
2020
122
0.100
Why?
Firmicutes
2
2023
7
0.100
Why?
Wounds and Injuries
2
2019
26
0.100
Why?
AIDS Vaccines
2
2018
152
0.100
Why?
Sex Factors
2
2014
227
0.090
Why?
Administration, Oral
1
2013
127
0.090
Why?
Analysis of Variance
1
2012
64
0.090
Why?
Alphapapillomavirus
1
2012
8
0.090
Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
33
0.090
Why?
Asymptomatic Diseases
1
2012
7
0.090
Why?
Zambia
3
2018
115
0.090
Why?
Safe Sex
1
2012
68
0.090
Why?
Self Disclosure
1
2012
8
0.090
Why?
Pain, Postoperative
1
2012
6
0.090
Why?
Focus Groups
2
2010
196
0.090
Why?
Reagent Strips
1
2011
2
0.090
Why?
Cytokines
2
2023
107
0.090
Why?
Multicenter Studies as Topic
2
2023
22
0.090
Why?
Likelihood Functions
1
2011
3
0.080
Why?
Least-Squares Analysis
1
2011
5
0.080
Why?
Infection Control
1
2011
31
0.080
Why?
Drug Resistance, Multiple, Bacterial
1
2011
37
0.080
Why?
RNA-Directed DNA Polymerase
1
2011
5
0.080
Why?
Nicotinic Agonists
1
2011
1
0.080
Why?
Chi-Square Distribution
1
2011
45
0.080
Why?
Models, Biological
2
2008
77
0.080
Why?
Health Surveys
1
2010
59
0.080
Why?
Drug Resistance, Bacterial
1
2011
135
0.080
Why?
AIDS Serodiagnosis
1
2011
44
0.080
Why?
Prenatal Care
1
2011
147
0.080
Why?
Menstruation Disturbances
1
2010
7
0.080
Why?
Menstruation
1
2010
10
0.080
Why?
Quality of Life
1
2011
177
0.070
Why?
Contraception Behavior
1
2010
54
0.070
Why?
Blood
1
2009
51
0.070
Why?
Mozambique
2
2021
55
0.070
Why?
Maternal Welfare
1
2009
9
0.070
Why?
Quality of Health Care
1
2009
62
0.070
Why?
Poverty Areas
1
2009
20
0.070
Why?
Clinical Trials, Phase III as Topic
2
2018
20
0.070
Why?
Program Development
1
2009
32
0.070
Why?
Early Diagnosis
2
2022
82
0.070
Why?
Bone Marrow
2
2022
19
0.070
Why?
Linkage Disequilibrium
2
2020
40
0.070
Why?
Colposcopy
1
2008
17
0.070
Why?
Gene Expression Regulation
2
2019
40
0.070
Why?
Papanicolaou Test
1
2008
29
0.070
Why?
Regression Analysis
1
2008
133
0.070
Why?
Microbial Viability
2
2019
11
0.070
Why?
Reference Values
1
2007
64
0.070
Why?
Cytomegalovirus
1
2007
24
0.070
Why?
Haplotypes
2
2019
125
0.070
Why?
Cytomegalovirus Infections
1
2007
23
0.060
Why?
Cote d'Ivoire
1
2007
6
0.060
Why?
Plasma
2
2019
39
0.060
Why?
Sequence Homology
1
2007
11
0.060
Why?
Models, Genetic
1
2007
13
0.060
Why?
Family Health
2
2018
16
0.060
Why?
Obesity
1
2010
367
0.060
Why?
Amino Acid Substitution
1
2007
35
0.060
Why?
Africa South of the Sahara
2
2023
353
0.060
Why?
Rwanda
2
2018
30
0.060
Why?
Kenya
2
2018
183
0.060
Why?
Drug Resistance, Microbial
1
2006
26
0.060
Why?
Mothers
2
2018
195
0.060
Why?
Disease Transmission, Infectious
2
2019
39
0.060
Why?
Polymorphism, Genetic
2
2020
99
0.060
Why?
Vietnam
1
2024
13
0.050
Why?
Cotinine
1
2024
7
0.050
Why?
Models, Statistical
1
2025
55
0.050
Why?
Flow Cytometry
1
2024
67
0.050
Why?
Real-Time Polymerase Chain Reaction
2
2016
90
0.050
Why?
Genome, Viral
1
2024
64
0.050
Why?
Treatment Failure
2
2016
175
0.050
Why?
Liver Cirrhosis
2
2015
28
0.050
Why?
Mucous Membrane
1
2023
12
0.050
Why?
Cough
1
2023
14
0.050
Why?
Ibuprofen
1
2023
3
0.050
Why?
Clinical Trials, Phase II as Topic
1
2023
10
0.050
Why?
Claudin-1
1
2023
2
0.050
Why?
Aspirin
1
2023
15
0.050
Why?
Computer Simulation
3
2009
56
0.050
Why?
Travel
1
2023
21
0.050
Why?
Anti-Inflammatory Agents
1
2023
39
0.050
Why?
Leukocytes, Mononuclear
1
2023
60
0.050
Why?
Network Meta-Analysis
1
2023
8
0.050
Why?
Methyltransferases
1
2022
2
0.050
Why?
DEAD-box RNA Helicases
1
2022
2
0.050
Why?
Ion Channels
1
2022
3
0.050
Why?
Decision Support Techniques
2
2017
7
0.050
Why?
Bordetella pertussis
1
2023
29
0.050
Why?
World Health Organization
1
2023
137
0.050
Why?
Receptors, Transferrin
1
2022
6
0.050
Why?
Ferritins
1
2022
23
0.050
Why?
Iron
1
2022
32
0.050
Why?
Proteomics
1
2022
15
0.050
Why?
Chemokine CCL3
1
2022
23
0.050
Why?
Homosexuality, Male
1
2022
52
0.050
Why?
Carrier State
1
2023
92
0.050
Why?
Nasopharynx
1
2023
151
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
2022
25
0.040
Why?
Genomics
1
2022
109
0.040
Why?
Neoplasm, Residual
1
2021
4
0.040
Why?
Diarylquinolines
1
2022
39
0.040
Why?
Autoantibodies
1
2022
49
0.040
Why?
Gene Rearrangement
1
2021
15
0.040
Why?
Ethiopia
1
2021
18
0.040
Why?
Genome-Wide Association Study
1
2022
106
0.040
Why?
Tongue
1
2021
5
0.040
Why?
Culture Media, Conditioned
1
2021
4
0.040
Why?
Models, Theoretical
2
2012
80
0.040
Why?
Shigella flexneri
1
2001
1
0.040
Why?
Dysentery, Bacillary
1
2001
3
0.040
Why?
Foodborne Diseases
1
2001
6
0.040
Why?
Confidence Intervals
1
2021
26
0.040
Why?
Animals
2
2021
1081
0.040
Why?
Immunoglobulins
1
2021
11
0.040
Why?
Lipoxygenase Inhibitors
1
2021
4
0.040
Why?
Cooking
1
2021
7
0.040
Why?
Antibodies, Neutralizing
1
2023
303
0.040
Why?
Algorithms
1
2021
106
0.040
Why?
Host-Pathogen Interactions
1
2021
24
0.040
Why?
Mycobacterium smegmatis
1
2021
20
0.040
Why?
International Cooperation
1
2001
50
0.040
Why?
Employment
1
2021
27
0.040
Why?
Sports
1
2001
43
0.040
Why?
Streptococcus pneumoniae
1
2023
336
0.040
Why?
Bacterial Proteins
1
2021
119
0.040
Why?
GPI-Linked Proteins
1
2020
5
0.040
Why?
Life Expectancy
2
2011
31
0.040
Why?
South America
1
2020
27
0.040
Why?
Brazil
1
2020
47
0.040
Why?
Cell Movement
1
2019
13
0.040
Why?
Chromosome Mapping
1
2019
20
0.040
Why?
pol Gene Products, Human Immunodeficiency Virus
1
2019
29
0.040
Why?
Waste Disposal Facilities
1
2019
9
0.040
Why?
Workload
1
2019
13
0.040
Why?
Income
1
2019
85
0.040
Why?
India
1
2019
62
0.040
Why?
Lymphocyte Subsets
1
2019
6
0.040
Why?
Immunogenetic Phenomena
1
2019
7
0.040
Why?
Mouthwashes
1
2019
3
0.040
Why?
Drinking Water
1
2019
3
0.040
Why?
Chlorhexidine
1
2019
10
0.040
Why?
Cluster Analysis
1
2019
65
0.040
Why?
CD8-Positive T-Lymphocytes
1
2019
48
0.040
Why?
Influenza B virus
1
2019
42
0.040
Why?
Human Genome Project
1
2018
7
0.040
Why?
Genetic Predisposition to Disease
1
2020
176
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
1
2019
36
0.040
Why?
Drug Costs
1
2018
18
0.040
Why?
Aftercare
1
2018
10
0.040
Why?
Program Evaluation
1
2019
89
0.040
Why?
Volition
1
2018
1
0.040
Why?
Research Personnel
1
2019
19
0.040
Why?
Models, Econometric
1
2018
3
0.040
Why?
Elective Surgical Procedures
1
2018
10
0.040
Why?
Alcoholism
1
2018
17
0.030
Why?
Actinomycetales
1
2018
2
0.030
Why?
Trehalose
1
2018
2
0.030
Why?
Naphthalimides
1
2018
2
0.030
Why?
Molecular Probes
1
2018
4
0.030
Why?
Mycobacterium
1
2018
16
0.030
Why?
CD4 Antigens
1
2018
49
0.030
Why?
Infant, Low Birth Weight
1
2018
35
0.030
Why?
Gestational Age
1
2018
80
0.030
Why?
Aged, 80 and over
1
2019
468
0.030
Why?
Reminder Systems
1
2017
8
0.030
Why?
Circulating Tumor DNA
1
2017
2
0.030
Why?
Diabetes Mellitus, Type 2
1
2019
139
0.030
Why?
Health Plan Implementation
1
2017
16
0.030
Why?
Post-Exposure Prophylaxis
1
2017
4
0.030
Why?
Text Messaging
1
2017
25
0.030
Why?
Forms and Records Control
1
1997
3
0.030
Why?
Pre-Eclampsia
1
2018
56
0.030
Why?
Medical Records
1
1997
23
0.030
Why?
Receptors, CXCR6
1
2017
3
0.030
Why?
Minimally Invasive Surgical Procedures
1
2017
3
0.030
Why?
Alternative Splicing
1
2017
4
0.030
Why?
NF-kappa B
1
2017
16
0.030
Why?
Spleen
1
2016
9
0.030
Why?
Pneumonia, Pneumocystis
1
2016
16
0.030
Why?
Cryptococcosis
1
2016
17
0.030
Why?
Breast Feeding
1
2017
120
0.030
Why?
Perception
1
2016
42
0.030
Why?
Area Under Curve
1
2015
20
0.030
Why?
Fetal Blood
1
2015
27
0.030
Why?
Microbial Sensitivity Tests
1
2016
198
0.030
Why?
DNA Methylation
1
2015
19
0.030
Why?
Influenza A Virus, H3N2 Subtype
1
2015
31
0.030
Why?
Molecular Targeted Therapy
1
2015
10
0.030
Why?
Influenza A Virus, H1N1 Subtype
1
2015
54
0.030
Why?
Hypertension
1
2019
419
0.030
Why?
Granuloma
1
2015
3
0.030
Why?
Chemical and Drug Induced Liver Injury
1
2015
12
0.030
Why?
Health Policy
1
2015
140
0.030
Why?
Hepatitis B Surface Antigens
1
2014
48
0.030
Why?
Survival Rate
1
2013
96
0.020
Why?
Biopsy, Needle
1
2012
4
0.020
Why?
Aspartate Aminotransferases
1
2012
10
0.020
Why?
Lymph Nodes
1
2012
13
0.020
Why?
Statistics, Nonparametric
1
2012
38
0.020
Why?
Length of Stay
1
2012
43
0.020
Why?
Skin
1
2012
38
0.020
Why?
Kidney
1
2012
46
0.020
Why?
Clinical Laboratory Techniques
1
2012
56
0.020
Why?
United Kingdom
1
2011
33
0.020
Why?
Medical Audit
1
2011
26
0.020
Why?
Thailand
1
2011
26
0.020
Why?
Voluntary Programs
1
2011
5
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
77
0.020
Why?
Costs and Cost Analysis
1
2011
42
0.020
Why?
Hepatitis B virus
1
2012
157
0.020
Why?
Social Stigma
1
2011
80
0.020
Why?
Amenorrhea
1
2010
9
0.020
Why?
Culture
1
2010
23
0.020
Why?
Consensus Sequence
1
2009
4
0.020
Why?
Decision Trees
1
2009
3
0.020
Why?
Herpes Genitalis
1
2010
43
0.020
Why?
Disease Reservoirs
1
2009
1
0.020
Why?
Virus Latency
1
2009
5
0.020
Why?
Contraceptive Agents, Female
1
2010
47
0.020
Why?
Anti-Infective Agents
1
2009
57
0.020
Why?
HIV Reverse Transcriptase
1
2008
41
0.020
Why?
Codon
1
2007
7
0.020
Why?
Molecular Sequence Data
1
2007
263
0.020
Why?
Pyrimidinones
1
2006
24
0.010
Why?
Lopinavir
1
2006
137
0.010
Why?
Ritonavir
1
2006
137
0.010
Why?
Viral Proteins
1
2005
30
0.010
Why?
Chickens
1
2001
5
0.010
Why?
Fruit
1
2001
5
0.010
Why?
Food Handling
1
2001
5
0.010
Why?
Zea mays
1
2001
5
0.010
Why?
Guidelines as Topic
1
2001
40
0.010
Why?
Beverages
1
2001
42
0.010
Why?
Residence Characteristics
1
2001
57
0.010
Why?
Martinson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (644)
Explore
_
Co-Authors (76)
Explore
_
Similar People (60)
Explore
_